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Purpose: We evaluated the expression and activation of Notch pathway genes in the adult human and murine corneal
epithelium during proliferation.
Methods: The expression of Notch pathway genes in the limbal and central human corneal epithelium was compared by
reverse  transcription  polymerase  chain  reaction  (RT–PCR).  Their  expression  pattern  was  examined  by
immunofluorescence and in situ hybridization. The temporal expression of Notch1 during murine wound healing was
assessed by RT–PCR. Notch activity was determined using western blot for the Notch intracellular domain (NotchIC).
The expression of Hes1 was evaluated in cell culture.
Results: The expression of Notch1 and Jagged1 was higher in the human limbal epithelium while the expression of Hes1
and Hes5 was higher in the central cornea. Expression of Notch1, Jagged1, and Hes1 was found predominantly in the
basal and immediate suprabasal cells. During neonatal corneal development, NotchIC was detected in occasional cells at
P10 while at P15 and P90, it was found in the basal and early suprabasal layers. NotchIC was found to be lower in the
limbal compared to central corneal epithelium. The expression of Notch1 was lower at 24 h post-wounding but was
completely restored in six days. The levels of NotchIC were decreased at 24 h post-wounding and after application of
topical phorbol myristate. In vitro, the expression of Hes1 was higher in confluent cells maintained under high calcium
conditions.
Conclusions: The inverse correlation between Notch signaling and the proliferative status of the corneal epithelium is
consistent with the idea that Notch plays a role in corneal epithelial differentiation.
The  cornea  is  covered  by  a  stratified  squamous
epithelium that functions to maintain transparency as well as
provide the first line of defense against pathogens and the
penetration  of  noxious  agents.  The  corneal  epithelium  is
continually losing cells due to desquamation (primarily via
the blink reflex) and thus must replace these cells to maintain
homeostasis. Such continuously renewing epithelia are by
definition  governed  by  stem  cells.  The  stem  cells  of  the
corneal epithelium are preferentially located in the limbal
region [1]. Upon division, the slow cycling limbal epithelial
stem  cells  give  rise  to  daughter  cells  known  as  transient
amplifying (TA) cells. The TA cells in turn undergo multiple
cell divisions giving rise to more differentiated epithelial cells
that migrate centrally and leave the basal layer toward the
superficial corneal epithelium [2,3]. This highly organized
differentiation  program  is  under  the  control  of  multiple
regulatory mechanisms, which remain largely unknown [4,
5].
The Notch signaling pathway plays a key role in the
proliferation and differentiation of many tissues. It is a highly
conserved network that orchestrates cell-fate decisions in the
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nervous, gastrointestinal, and the hematopoietic systems of
many  organisms  ranging  from  insects  to  humans.  Notch
proteins are large transmembrane proteins. Four Notch genes
have been identified in mammals (Notch1-Notch4), and their
mutations cause severe abnormalities in organ development
and adult homeostasis [6]. In addition, three Delta (Delta like
1, 3, and 4) and two Jagged (Jagged1 and Jagged2) proteins
have been identified as Notch ligands in mammals. Notch
signaling is initiated by the interaction between the ligand on
one  cell  and  the  receptor  on  a  neighboring  cell.  This
interaction  triggers  the  proteolytic  cleavage  of  the  Notch
receptor at the membrane proximal region by the γ-secretase
presenilin [7,8]. In the most well characterized “canonical”
pathway in mammalian cells, the Notch intracellular domain
(NotchIC)  translocates  to  the  nucleus  where  it  mostly
associates with the recombination signal binding protein for
the immunoglobulin kappa J region (RBPJκ). The NotchIC/
RBPJκ complex transactivates protein targets such as Hairy/
Enhancer of Split (HES) and Hairy/Enhancer of Split-related
with  YRPW  motif  (HEY)  genes,  which  in  turn  affect
numerous pathways involving cell-fate determination [9].
The role of Notch signaling in the corneal epithelium has
not been studied in detail. Its importance in corneal epithelial
proliferation and differentiation was initially discovered while
studying Notch1 in the mouse epidermis. When Notch1 was
conditionally  deleted  in  the  epidermis  and  the  corneal
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1041epithelium  of  postnatal  mice,  hyperproliferation  and
abnormal differentiation were noted in the epidermis and the
corneal epithelium [10]. In the present study, we confirm and
extend further the role of Notch signaling in the adult corneal
epithelium by demonstrating that Notch activity is down-
regulated in the corneal epithelium during the early phase of
proliferative conditions.
METHODS
Immunostaining: Three human corneas (obtained from the
Illinois Eye Bank) or mouse whole eyes were embedded in
OCT and then cut into 8 μm sections. The sections were fixed
for 10 min in chilled acetone and blocked with 5% donkey
serum  for  1  h  at  room  temperature.  The  sections  were
incubated for 90 min at room temperature with rat monoclonal
anti-Notch1  antibody  (Developmental  Studies  Hybridoma
Bank, Iowa City, IA), rabbit polyclonal anti-Notch 1 (1:100)
or goat polyclonal anti-Jagged1 (1:100; both from Santa Cruz
Biotechnology, Santa Cruz, CA) or a rabbit polyclonal anti-
cleaved Notch-1 (1:200; Cell Signaling Technology, Danvers,
MA or Abcam, Cambridge, MA) or rabbit monoclonal anti-
Ki67 (1:250; Labvision, Fremont, CA). For a negative control,
the sections were incubated with an irrelevant (no epithelial
expression  of  the  antigen)  rabbit  or  goat  antibody.  A
fluorescein-conjugated donkey anti-rabbit (1:200) or donkey
anti-goat (1:200) was used for 1 h at room temperature. The
slides were counterstained with DAPI or propidium iodide,
visualized using a Zeiss Axiovert fluorescence microscope,
and photographed with an AxioCam (Carl Zeiss, Thornwood,
NY) camera. For immunohistochemistry, a similar protocol
was  followed  except  a  biotin-conjugated  goat  anti-rabbit
antibody (1:500) was used, and sections were incubated in
streptavidin peroxidase complex before being developed in
3,3′  diaminobenzadine  (all  from  Vector  Laboratories,
Burlingame, CA).
Relative quantitative reverse transcription polymerase chain
reaction: Epithelial cells from the central corneal and limbal
regions were separately removed from three fresh eye bank
corneas (donor ages 41, 56, and 62). Specifically, a 7.5 mm
trephine  was  used  to  excise  the  central  cornea  leaving  a
1.5 mm area of limbal epithelium intact. The central button
and the limbal rims were placed in dispase (5 mg/ml) for 1 h
at 37 °C, and the epithelium was gently separated from the
underlying stroma by blunt dissection and stored in RNAlater
(Qiagen, Valencia, CA). For the animal experiments, corneas
that were removed following euthanasia were similarly stored
in RNAlater.
Total RNA was isolated from the human epithelial cells
(limbal  and  central)  or  the  mouse  corneal  epithelium  per
manufacturer’s  instructions  (RNeasy  Protect  Mini  Kit,
Qiagen). Reverse transcription was performed with 0.5 µg
total RNA using random hexamers and a cDNA synthesis kit
(SuperScript  First-Strand  Synthesis  System,  Invitrogen,
Carlsbad,  CA).  Relative  quantitative  polymerase  chain
reaction  (PCR)  was  performed  according  to  the
manufacturer’s  instructions  (QuantumRNA  Universal  kit;
Ambion, Austin, TX) using primer sets for 18S rRNA as an
internal standard and intron-spanning primers for human or
mouse  Notch1,  Notch2,  Delta1,  Jagged1,  Jagged2,  Hes1,
Hes5, DeltaN-p63, and ABCG2. The linear range of the PCR
for each target gene was determined experimentally using
cDNA from the control sample. The cycle number in the
middle of the linear range of the PCR was chosen for each
specific  target  gene.  Following  the  manufacturer’s
instructions, the primers for the 18S rRNA were mixed with
varying ratios of competimers (ranging from 1:9 to 4:6) to find
the optimal primer:competimer ratio, which provided near
equal bands for 18S and the target gene. For each sample, a
multiplex  PCR  for  both  the  target  gene  and  18S  internal
standard was then performed and the products were visualized
on 1.2% agarose gels after ethidium bromide staining. All
samples were run in duplicates and repeated a minimum of
three times. For every primer set, a sample with no reverse
transcriptase was used as the negative control.
The band densities from each reaction were quantified
(Digital  Science  Image  Station,  model  440CF;  Eastman
Kodak,  Rochester,  NY)  and  subsequently  normalized  by
dividing the band density of the target gene by the density of
its corresponding 18S band. The normalized densities were
converted into a ratio between the central cornea and the
limbus and reported as means±standard deviation. Statistical
comparison was performed using Student’s t-test and a p value
less than 0.05 was considered significant.
In situ hybridization: In situ hybridization was performed on
human corneal paraffin sections [11]. Both the sense (negative
control) and anti-sense probes were digoxigenin-labeled RNA
probes.  The  RNA  probes  were  synthesized  by  in  vitro
transcription  (Riboprobe  In  Vitro  Transcription  System,
Promega,  Madison,  WI)  using  T7  RNA  polymerase,
digoxigenin labeled UTP (Roche, Nutley, NJ), and a template
amplified from cDNA by PCR. The template was a 624-bp
region in the UTR of Hes1 and was amplified such that the
sequence for the T7 bacteriophage promoter was built into the
reverse primer sequence (Forward: 5′-ATC AAT GCC ATG
ACC TAC CC-3′, Reverse: 5′-CTA ATA CGA CTC ACT
ATA GGG AGG CGC AAT CCA ATA TGA AC-3′). The T7
promoter sequence was built into the forward primer for sense
probe synthesis.
The  sections  were  deparaffinized,  digested  with
proteinase  K  (10  µg/µl),  and  post-fixed  in  1%
paraformaldehyde. After pre-hybridization, the sections were
incubated  with  the  pre-heated  Hes1  probe  (diluted  in
hybridization solution) overnight at 50 °C and sequentially
washed with serial dilutions of sodium chloride sodium citrate
(SSC)  buffer.  The  sections  were  incubated  at  room
temperature with blocking solution for 1.5 h followed by
incubation with 1:500 alkaline phosphatase-conjugated anti-
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washed and incubated further with nitroblue tetrazolium/ 5-
bromo-4-chloro-3-indolyl-phosphate  chromogen  (NBT/
BCIP) for 30–120 min at room temperature in the dark and
then  rinsed  and  mounted  with  Vectashield  (Vector
Laboratories, Burlingame, CA). Positive reaction products
appeared purplish blue.
Mouse model of corneal epithelial wound healing: A mouse
model of corneal epithelial wound healing was used to study
the  expression  of  Notch  pathway  components  under
proliferative conditions [12]. Six-month-old C57Bl/6 mice
were  anesthetized  with  an  intraperitoneal  injection  of
ketamine (100 mg/kg) and xylazine (5 mg/kg). After applying
several drops of topical 0.5% proparacaine, a 1.5-mm area of
the central epithelium was demarcated and removed by gentle
scraping (excluding the limbal area). At 24-h, 48-h, and144-
h  post-wounding  time  points,  the  corneal  epithelium  was
removed by scraping (different mice used for each time point).
Between 8 and 10 corneal epithelial scrapings were pooled
together for each time point. Total RNA was extracted from
the samples and subjected to relative quantitative RT–PCR
with 18S rRNA as an internal standard (Ambion).
Pharmacologic induction of corneal epithelial proliferation
in  vivo:  To  stimulate  proliferation  of  the  ocular  surface
epithelial cells, the tumor promoting agent phorbol myristate
ester (TPA) was dissolved in pertolatum at a concentration of
0.5%. This concentration has been demonstrated to induce a
hyperproliferative response that maximizes after 24 h with the
absence  of  necrosis  [13].  Six-month-old  C57BL/6  mice
received topical 0.5% TPA in petrolatum while the control
mice received petrolatum alone. Corneas were harvested after
24 h and prepared for western blot analysis.
Western blot: Following homogenization, the mouse corneal
proteins  were  extracted  overnight  with
radioimmunoprecipitation assay (RIPA) buffer supplemented
with protease inhibitors. Equal amounts of each sample were
mixed with sample buffer (Invitrogen), denatured by heating
at 95 °C for 10 min, and subjected to electrophoresis on 10%–
20%  Tricine  gels  (Invitrogen).  The  protein  bands  were
transferred to nitrocellulose membranes, and equal loading
was verified by Ponceau S staining. The membranes were
incubated in 3% BSA in Tris-buffered saline for 1 h followed
by an overnight incubation (4 °C) with rabbit anti-NotchIC
antibody  (1:1000;  Cell  Signaling).  The  membranes  were
washed with Tris-buffered saline with 0.05% Tween 20 and
incubated with HRP-goat-anti rabbit IgG (1:5000) for 1 h at
room temperature. Detection was performed with enhanced
chemiluminescence  reagents  (Pierce  Biotechnology,
Rockford,  IL)  and  recorded  on  film  (Kodak  X-OMAT;
Eastman Kodak Co., Rochester, NY).
Cell culture: Human corneal epithelial cultures were initiated
from corneoscleral rims obtained from eye bank eyes. The
rims were treated with dispase (10 mg/ml) at 4 °C overnight
to disrupt the basement membrane. The epithelial sheets were
peeled off and digested in 0.25% trypsin-EDTA at 37 °C for
5–10  min.  Cells  were  washed  and  resuspended  in  a
keratinocyte  serum-free  medium  (KSFM;  Invitrogen)  and
plated in tissue culture plates. After the first passage, the cells
were  plated  at  either  low  density  (20%–30%  confluence)
where proliferation is induced or high density cultures (>90%
confluence)  where  proliferation  is  inhibited.  To  induce
differentiation,  the  low  density  cultures  were  exposed  to
1.6 mM calcium. At 48 h, the cultured epithelial cells were
trypsinized and subjected to relative quantitative RT–PCR
with normalization to 18S.
RESULTS
Expression of Notch pathway genes in the human limbal and
central corneal epithelium: Human corneal epithelial cells
isolated from fresh eye bank eyes were initially screened for
the presence or absence of Notch pathway genes by RT–PCR.
Expression of Notch1, Notch2, Delta1, Jagged1, Jagged2,
Hes1, and Hes5 was observed with all transcripts detected at
28 cycles or less. The transcripts for Delta4, Hes2, Hey1, Hey
2, and HeyL were detected only after amplification for 35–40
cycles.  These  genes  were  considered  to  be  of  very  low
abundance, and the possibility of non-epithelial origin of their
expression  (e.g.,  resident  immune  cells)  could  not  be
excluded. The expression of Notch3, Notch4, Delta3, and
Hes3 was not detected in the human corneal epithelium.
Using relative quantitative RT–PCR, the expression of
the Notch pathways genes was compared between the limbal
and the central corneal epithelium. The limbal expression of
Notch1 receptor and Jagged1 ligand was respectively 30%
±14% and 19%±7% fold lower in the central cornea. On the
other hand, the expression of the canonical Notch downstream
targets,  Hes1  and  Hes5,  were  42%±10%  and  66%±22%
higher, respectively, in the central cornea compared to the
limbus (p<0.05). There was no statistical difference in the
level of expression of Notch2, Delta1, and Jagged2 between
the  limbal  and  central  corneal  epithelium.  As  a  positive
control, the expression of limbal markers, DeltaN-p63 and
ATP-binding cassette transporter isoform G2 (ABCG2), were
both markedly higher in the limbus as previously described
[14,15].  Overall,  these  results  demonstrate  that  while  the
Notch1 receptor is expressed at a higher level in the limbus,
the level of Notch activity as measured by the expression of
its downstream targets, Hes1 and Hes5, is higher in the central
corneal epithelium (Figure 1).
By immunofluorescence, both Notch1 and Jagged1 were
found  to  be  expressed  predominantly  in  the  basal  and
suprabasal layers of the human corneal epithelium (Figure
2A,C). Notch1-stained cells extended higher in the limbal
epithelium (Figure 2B) than in the corneal epithelium (Figure
2A).
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target of Notch, was evaluated by in situ hybridization. Its
expression  was  localized  to  the  basal  and  immediate
suprabasal layers of the corneal epithelium (Figure 3A). In
comparison, a more patchy expression pattern was detected in
the limbal epithelium (Figure 3B). Overall, the expression
pattern of Hes1, which indicates Notch activation in the basal
and  suprabasal  cell  layers,  was  consistent  with  the
immunofluorescent  expression  patterns  of  Notch1  and
Jagged1.
Activation of Notch in the mouse corneal epithelium during
development and during proliferative states: During mouse
corneal development, the rate of proliferation as measured by
the labeling index increases steadily in the first week of life
and peaks at around P7-P10. The rate of proliferation then
begins to decline rapidly before eye opening around P12. By
P15, the proliferation is approaching the same level typically
seen  in  adult  corneal  epithelium  [16].  Therefore,  Notch
activation in the mouse cornea was evaluated during these
periods  by  immunohistochemistry.  At  P10,  NotchIC  was
Figure  1.  Relative  quantitative  reverse  transcription  polymerase
chain reaction comparing the expression of Notch pathway genes
between the limbal and central human corneal epithelium. All results
are after normalization to 18S rRNA. Higher expression in the central
cornea  is  noted  for  Hes1  (1.4  fold)  and  Hes5  (1.7  fold).  The
expression of Notch1 (0.7 fold) and Jagged1 (0.8 fold) was lower in
the  central  cornea  compared  to  the  limbus.  The  expression  of
Jagged2, Notch2, and Delta1 appeared slightly lower in the central
cornea, but this did not reach statistical significance (*p<0.05). As a
positive control, the expression of limbal markers, DeltaNp63 and
ABCG2, was markedly higher in the limbus than the central cornea.
Representative gels of the relative quantitative RT–PCR for Hes1
and Hes5 are shown.
detected  in  occasional  basal  or  suprabasal  cells.  By  P15,
NotchIC was detected in most of the basal cells, and by P90,
it was detectable in all of the basal and early suprabasal cells
of the corneal epithelium (Figure 4A-C). At P90, NotchIC
staining was seen mostly in the suprabasal cells and very few
basal cells in the limbal epithelium (Figure 4D). In general,
the limbal epithelium demonstrated less NotchIC compared
to  the  central  cornea.  Therefore,  it  appears  that  in  the
developing  mouse  corneal  epithelium,  Notch  activity  is
inversely correlated with the degree of proliferation.
During wound healing, the corneal epithelial cells that
were peripheral to the wounded area have been shown to
undergo proliferation [17]. The level of Notch activation in
the peripheral cornea was therefore evaluated following a
central 1.5-mm epithelial wound. At 24 h, NotchIC staining
was found to be reduced in the corneal epithelium that was
peripheral to the wounded area (Figure 5A) compared to the
same region in a non-wounded mouse cornea (Figure 5B).
The expression pattern of Notch1 in the adult mouse
corneal  epithelium was  examined  by  immunofluorescence
(Figure 6A). Under normal conditions, Notch1 was found to
be expressed in the basal and immediate suprabasal cells of
the mouse corneal epithelium, similar to what was observed
in human corneas. Notch1 was expressed in the epithelial cells
at  the  leading  edge,  albeit,  at  reduced  levels  24  h  after
wounding (Figure 6B).
The mRNA expression of Notch1 was evaluated 24 h, 48
h, and 144 h after wounding by relative quantitative RT–PCR.
The results indicated down-regulation of the Notch1 receptor
at  24  h  following  injury  (p<0.001).  The  expression  level
increased beyond the baseline at 48 h and was back to baseline
in six days (Figure 7).
Figure 2. Immunofluorescence staining for Notch1 and Jagged1.
Notch1 (A and B) and Jagged1 (C and D) staining is noted in the
basal and immediate suprabasal layers of central human cornea (A
and C) and limbus (B and D). Inset show the nuclear staining of the
sections with DAPI. Bar=30 μm.
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1044To quantify Notch activation at the protein level, the
levels of the active intracellular domain of Notch (NotchIC)
was  compared  by  western  blot  analysis.  At  24  h  post-
wounding and 24 h after TPA treatment, the levels of NotchIC
was significantly suppressed, indicating down-regulation of
Notch activity during these hyperproliferative states (Figure
8A). The increased proliferation in the cornea epithelium was
confirmed by Ki67 staining. As expected, the TPA-treated
corneal  epithelium  demonstrated  the  highest  level  of
proliferation followed by the wounded corneal epithelium and
the normal mouse cornea (Figure 8B-D).
Expression of Hes1 in human corneal epithelial cells in vitro:
The level of canonical Notch activity as measured by the
expression of Hes1 was examined under in vitro conditions.
Primary human corneal epithelial cells after the first passage
were  cultured  at  high  or  low  densities  and  high  or  low
(0.09 mM) calcium. The expression of Hes1 was 1.5 fold
higher  in  high  density  compared  to  low  density  cultures
(p<0.05). Increasing the calcium concentration to 1.6 mM,
which induces differentiation of the corneal epithelial cells,
likewise enhanced the expression by twofold (p<0.05). These
results  demonstrate  that  the  level  of  Notch  activity  as
measured by the expression of Hes1 is higher in conditions
where there is less proliferation and a greater commitment
toward differentiation. These results corroborate the in vivo
findings that Notch activity is down-regulated in response to
hyperproliferation (Figure 9).
Figure 3. In situ hybridization of the human Hes 1 gene. In both the
central  corneal  epithelium  (A)  and  the  limbal  epithelium  (B),
expression of Hes1 is seen predominantly in the basal layer with
some  extension  into  the  suprabasal  layers.  The  intensity  of  the
staining was slightly lower in the limbus. The areas with darker
staining observed in the limbal basal epithelium (arrows) actually
represent underlying pigmentation of the tissue. The pigmented cells
in the limbus are seen more clearly in C, which represents the same
section  in  B  without  the  purple  staining.  Minimal  non-specific
staining is observed in the sense control in the central cornea (D).
Bar=30 μm.
DISCUSSION
Notch signaling is a fundamental pathway that controls cell
fate  decisions  during  development  and  differentiation  in
nearly  all  tissues.  In  the  epidermis,  a  structure  which  is
morphologically  similar  to  the  corneal  epithelium,  Notch
signaling functions as a commitment switch that signals the
epithelial cells to leave the basal layer and begin terminal
differentiation  [18,19].  In  the  murine  epidermis,  Notch
signaling  was  shown  to  limit  proliferation  by  inhibiting
DeltaNp63α, a cell cycle regulator important for maintaining
the proliferative capacity of epidermal progenitor cells [20].
Inhibition  of  Notch  signaling  was  found  to  suppress
keratinocyte  commitment  to  differentiation  and  expand
populations with stem cell potential [18]. Clinically, Notch is
demonstrated  to  be  down-regulated  in  hyperproliferative
conditions such as psoriasis and squamous and basal cell
carcinomas  [18,21].  Likewise,  in  animal  models,  Notch
expression is reduced in the first 24 h after wounding of the
skin [22].
The  importance  of  Notch  signaling  in  the  corneal
epithelium was first noted in a study involving the conditional
knockout of Notch1 in the postnatal mouse epidermis [10].
When  Notch1  was  conditionally  deleted  using  the  basal
corneal epithelium-active keratin14 or keratin5 promoter, the
mice  developed  hyperplastic,  keratinized,  skin-like
epithelium in the cornea [10]. This phenotype was particularly
manifested  after  repeated  corneal  epithelial  scraping  [23].
Mechanistically, Notch1 was shown to regulate vitamin A
Figure 4. Immunohistochemical staining for NotchIC, the cleaved
Notch intracellular fragment in developing mouse corneas. A: At
P10, weak NotchIC staining is found in occasional basal cell of the
corneal epithelium. B: By P15, NotchIC is present in many of the
basal cells. (C) At P90, NotchIC is found throughout the basal and
immediate suprabasal layers of the mouse corneal epithelium. D: In
the limbal epithelium at P90, NotchIC is seen in few cells, mostly in
suprabasal cells. The area closest to the central cornea (left side of
the  tissue)  demonstrates  more  staining.  Incidentally,  NotchIC
staining is also noted in the keratocytes (A-D). Bar=30 μm.
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1045metabolism  in  the  corneal  epithelium  by  regulating  the
expression of cellular retinol binding protein 1 [23]. These
results are confirmed and further extended by our current
study where we found Notch activity to be down-regulated
during  proliferative  states  in  the  corneal  epithelium.  We
surmise that Notch signaling must first be down-regulated
during the initial stages of wound healing to allow epithelial
cells to revert to a more basal and undifferentiated “wound
healing” phenotype. Later, when the epithelial defect has been
covered by a provisional epithelium, Notch signaling must be
restored for the proper differentiation of the corneal epithelial
cells  to  take  place.  Thus,  in  the  absence  of  Notch1,  the
epithelial cells remain in an undifferentiated basal phenotype,
which by default follow an epidermal fate.
In this study, we found Notch to be more active in the
central corneal epithelium than in the limbus. The level of
Notch  activation  as  judged  by  the  expression  of  its
downstream targets, Hes1 and Hes5, was 1.42 and 1.66 fold
higher in the human central corneal epithelium compared to
the limbal epithelium. The result for Hes1 is consistent with
that from a previous study in which serial analysis of gene
expression found Hes1 expression in the rat central epithelium
to be 1.33 fold higher than in the limbal epithelium [24].
Overall, this is consistent with the fact that the central corneal
epithelium  has  less  proliferative  capacity  and  more
commitment toward differentiation compared to the limbus
[3].
The expression pattern of Notch1, Jagged1, and Hes1 in
the basal and immediate suprabasal cells further supports the
Figure 5. Immunohistochemical staining for NotchIC in the cornea
of a wounding mouse model. A: NotchIC is seen in just a few basal
and some suprabasal cells 24 h after wounding. B: In the unwounded
control mouse cornea, NotchIC staining is demonstrated in the basal
and suprabasal cells of the corneal epithelium. The NotchIC staining
is stronger in the unwounded cornea (compare B versus A). Bar=30
μm.
involvement  of  Notch  in  the  commitment  of  a  cell  to
proliferate or differentiate. The expression of Notch1 receptor
being primarily in the basal and early suprabasal cells of
mouse and human corneal epithelium with a slightly higher
expression in the limbal epithelium compared to the central
cornea is consistent with other reports using fresh tissue or
freshly isolated population of cells [23,25,26]. In contrast,
Notch1 expression has been shown to be limited to the corneal
suprabasal cells with minimal expression in the corneal basal
cells and the limbal epithelium [27]. This difference is most
likely due to the choice of primary antibodies. In the present
study, we used a rat monoclonal antibody to detect the Notch1
receptor in a manner similar to that of Thomas et al. [26] while
Ma et al. [27] used a polyclonal rabbit antibody. Using a
different antibody against NotchIC, the active form of Notch,
both our laboratory and Vauclair et al. [23] found Notch to be
active in the basal and suprabasal cells of murine corneal
epithelium.  It  is  important  to  recognize  that  while  Notch
receptors and ligands are present both in the limbal and the
Figure  6.  Immunofluorescence  for  Notch1  in  the  cornea  of  a
wounding  mouse  model.  A:  Notch1  expression  is  noted
predominantly in the basal and early suprabasal cells in unwounded
mouse corneas. B: Scattered expression of Notch1 is seen in the new
epithelium near the leading edge (arrowhead) 24 h after wounding.
Nuclei were stained with DAPI in blue. Bar=30 μm.
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1046central corneal epithelium, the actual level of Notch activity
appears to be greater in the central corneal epithelium. This is
evident by the higher expression of downstream Hes factors
in the central cornea and by the phenotype of the Notch1
conditional  knockouts  where  the  central  cornea  develops
keratinization while the limbus is relatively spared [10,23].
It is interesting to note that the expression pattern of
Notch1 and Hes1 in the corneal epithelium is slightly different
from  the  epidermis  where  their  expression  is  primarily
suprabasal.  This  may  reflect  inherent  differences  in  the
architecture of these tissues. In particular, as previous studies
have suggested, the basal cells in the peripheral and central
corneal epithelia behave more like the suprabasal cells in the
epidermis  while  the  basal  layer  of  the  epidermis,  which
contains the most undifferentiated cells, is more analogous to
the basal epithelium of the limbus [28-30].
The down-regulation of Notch during proliferative states
was further demonstrated in the developing mouse cornea as
well as the mouse models of corneal wound healing and TPA-
induced  proliferation.  In  these  latter  models,  the  rate  of
proliferation  peaks  in  the  first  24  h  [13,31].  Our  results
indicate a clear down-regulation of Notch signaling at 24 h
when  the  corneal  epithelial  cells  are  most  actively
proliferating and their differentiation program is temporarily
suspended. After 24 h, the level of Notch is quickly restored
as the demand for proliferation is reduced and the need arises
to re-establish the differentiation program.
The  in  vitro  studies  further  confirm  the  in  vivo
observations. Specifically, Notch activity as measured by the
levels of Hes1 is increased in culture conditions that limit
proliferation and promote differentiation. Notch is suppressed
during  hyperproliferative  states  when  growth  and
Figure 7. Expression of Notch1 in the mouse corneal epithelium after
wounding  as  determined  by  relative  quantitative  reverse
transcription polymerase chain reaction. The expression levels are
presented relative to the baseline unwounded samples. When the rate
of proliferation had peaked at 24 h, Notch1 expression was reduced
(78%±3%, p<0.001). By 48 h, the expression had recovered and
increased beyond the baseline. After six days, Notch1 returned to
baseline levels.
proliferation is more important than differentiation. These
results are also consistent with the findings of Thomas et al.
who  found  Notch  expression  to  be  absent  in  the  actively
dividing corneal epithelial cells in culture. On the other hand,
exogenous Notch activation or inhibition in human corneal
epithelial cells appears to have the opposite effect. A study by
Ma  et  al.  found  that  Notch  inhibition  by  the  γ-secretase
inhibitor,  L-685458,  reduced  proliferation  and  promoted
differentiation  while  Notch  activation  by  soluble  Jagged1
increased proliferation and inhibited differentiation in corneal
epithelial cell cultures [27]. The reason for these seemingly
contradictory  results  may  due  in  part  to  the  non-Notch
mediated effects of γ-secretase inhibitor as well as the dose
dependant effects of Notch. In particular, previous studies in
neuronal cell cultures have shown that high and low levels of
Notch activation actually have the opposite effects [32]. A
similar phenomenon is seen in other signaling systems such
as TGF-β where high and low levels of the cytokine have the
opposite effect on cell proliferation [33]. Current studies are
Figure  8.  Western  blotting  for  the  cleaved  Notch  intracellular
domain.  A:  The  results  demonstrate  reduced  levels  of  Notch
intracellular domain (NotchIC) at 24 h after wounding (Wd) and after
TPA  treatment.  Immunofluorescence  staining  for  Ki67  (green)
demonstrates the number of proliferating basal cells to be highest in
the TPA-treated cornea at 24 h (B) followed by the wounded cornea
at 24 h (C) and a normal unwounded cornea (D). The nuclei are
stained red with propidium iodide.
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1047underway to determine the in vivo effects of exogenous Notch
activation and inhibition in the mouse corneal epithelium.
In summary, we have demonstrated that Notch signaling
is active in the basal and suprabasal corneal epithelial cells.
Notch  activity  is  inversely  proportional  to  the  degree  of
proliferation, confirming its role in controlling proliferation
and promoting differentiation. In the epidermis, studies have
shown that it may be possible to modify the Notch activity to
inhibit differentiation and expand the stem cell population
[18]. Based on the similarity of the corneal epithelium with
the epidermis, Notch signaling may also provide a potential
therapeutic pathway by which corneal epithelial proliferation
and differentiation can be manipulated. This may be valuable
for in vitro applications such as culturing epithelial cells for
clinical use and for in vivo conditions such as partial limbal
stem cell deficiency.
ACKNOWLEDGMENTS
This research was supported by a Fight for Sight Grant-in-Aid,
a career development grant K08EY017561-A1 to ARD, and
a core grant EY01792 both from the National Institutes of
Health, Bethesda, Maryland. ARD is also the recipient of a
Career  Development  Award  from  Research  to  Prevent
Blindness.  The  authors  thank  Ruth  Zelkha,  MS,  for  her
generous technical assistance with preparing the images.
REFERENCES
1. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside
in  the  bulge  area  of  pilosebaceous  unit:implications  for
follicular stem cells, hair cycle, and skin carcinogenesis. Cell
1990; 61:1329-37. [PMID: 2364430]
2. Cotsarelis G, Kaur P, Dhouailly D, Hengge U, Bickenbach J.
Epithelial  stem  cells  in  the  skin:  definition,  markers,
localization  and  functions.  Exp  Dermatol  1999;  8:80-8.
[PMID: 10206725]
3. Lehrer MS, Sun TT, Lavker RM. Strategies of epithelial repair:
modulation  of  stem  cell  and  transit  amplifying  cell
proliferation.  J  Cell  Sci  1998;  111:2867-75.  [PMID:
9730979]
4. Lavker RM, Tseng SC, Sun TT. Corneal epithelial stem cells at
the limbus: looking at some old problems from a new angle.
Exp Eye Res 2004; 78:433-46. [PMID: 15106923]
5. Stepp MA, Zieske JD. The corneal epithelial stem cell niche.
Ocul Surf 2005; 3:15-26. [PMID: 17131002]
6. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling:
cell  fate  control  and  signal  integration  in  development.
Science 1999; 284:770-6. [PMID: 10221902]
7. Schroeter  EH,  Kisslinger  JA,  Kopan  R.  Notch-1  signalling
requires ligand-induced proteolytic release of intracellular
domain. Nature 1998; 393:382-6. [PMID: 9620803]
8. Struhl G, Greenwald I. Presenilin is required for activity and
nuclear  access  of  Notch  in  Drosophila.  Nature  1999;
398:522-5. [PMID: 10206646]
9. Lai  EC.  Keeping  a  good  pathway  down:  transcriptional
repression of Notch pathway target genes by CSL proteins.
EMBO Rep 2002; 3:840-5. [PMID: 12223465]
10. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort
M, Hui CC, Clevers H, Dotto GP, Radtke F. Notch1 functions
as  a  tumor  suppressor  in  mouse  skin.  Nat  Genet  2003;
33:416-21. [PMID: 12590261]
11. Nakamura  H,  Ueda  J,  Sugar  J,  Yue  BY.  Developmentally
regulated  expression  of  Sp1  in  the  mouse  cornea.  Invest
Ophthalmol Vis Sci 2005; 46:4092-6. [PMID: 16249485]
12. Stepp  MA,  Spurr-Michaud  S,  Gipson  IK.  Integrins  in  the
wounded and unwounded stratified squamous epithelium of
the cornea. Invest Ophthalmol Vis Sci 1993; 34:1829-44.
[PMID: 8473121]
13. Lavker  RM,  Wei  ZG,  Sun  TT.  Phorbol  ester  preferentially
stimulates mouse fornical conjunctival and limbal epithelial
cells to proliferate in vivo. Invest Ophthalmol Vis Sci 1998;
39:301-7. [PMID: 9477986]
14. Budak MT, Alpdogan OS, Zhou M, Lavker RM, Akinci MA,
Wolosin  JM.  Ocular  surface  epithelia  contain  ABCG2-
dependent side population cells inhibiting features associated
with  stem  cells.  J  Cell  Sci  2005;  118:1715-24.  [PMID:
15811951]
15. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi
I,  Bondanza  S,  Ponzin  D,  McKeon  F,  De  Luca  M.  p63
identifies keratinocyte stem cells. Proc Natl Acad Sci USA
2001; 98:3156-61. [PMID: 11248048]
16. Tseng  H,  Matsuzaki  K,  Lavker  RM.  Basonuclin  in  murine
corneal and lens epithelia correlates with cellular maturation
and  proliferative  ability.  Differentiation  1999;  65:221-7.
[PMID: 10653358]
17. Chung  EH,  Hutcheon  AE,  Joyce  NC,  Zieske  JD.
Synchronization of the G1/S transition in response to corneal
debridement. Invest Ophthalmol Vis Sci 1999; 40:1952-8.
[PMID: 10440248]
18. Lefort  K,  Mandinova  A,  Ostano  P,  Kolev  V,  Calpini  V,
Kolfschoten I, Devgan V, Lieb J, Raffoul W, Hohl D, Neel
V, Garlick J, Chiorino G, Dotto GP. Notch1 is a p53 target
Molecular Vision 2008; 14:1041-1049 <http://www.molvis.org/molvis/v14/a125> © 2008 Molecular Vision
1048
Figure 9. Expression of Hes1 in corneal epithelial cultures. The level
of canonical Notch activity in human corneal epithelial cell cultures
was determined by relative quantitative RT–PCR of the downstream
target, Hes1. After normalization to 18S, the level of Hes1 in the low
density cultures (20%–30% confluence) was arbitrarily set at 100%.
High density cultures demonstrated a 1.5 fold increase (151%±5%,
p<0.05) and high calcium cultures expressed a 2.2 fold (219%±48%,
p<0.05) increase in the level of Hes1 relative to the low density
cultures.gene  involved  in  human  keratinocyte  tumor  suppression
through negative regulation of ROCK1/2 and MRCKalpha
kinases. Genes Dev 2007; 21:562-77. [PMID: 17344417]
19. Blanpain C, Lowry WE, Pasolli HA, Fuchs E. Canonical notch
signaling functions as a commitment switch in the epidermal
lineage. Genes Dev 2006; 20:3022-35. [PMID: 17079689]
20. Nguyen BC, Lefort K, Mandinova A, Antonini D, Devgan V,
Della Gatta G, Koster MI, Zhang Z, Wang J, di Vignano AT,
Kitajewski J, Chiorino G, Roop DR, Missero C, Dotto GP.
Cross-regulation  between  Notch  and  p63  in  keratinocyte
commitment  to  differentiation.  Genes  Dev  2006;
20:1028-42. [PMID: 16618808]
21. Thelu  J,  Rossio  P,  Favier  B.  Notch  signalling  is  linked  to
epidermal cell differentiation level in basal cell carcinoma,
psoriasis  and  wound  healing.  BMC  Dermatol  2002;  2:7.
[PMID: 11978185]
22. Cooper L, Johnson C, Burslem F, Martin P. Wound healing and
inflammation  genes  revealed  by  array  analysis  of
'macrophageless' PU.1 null mice. Genome Biol 2005; 6:R5.
[PMID: 15642097]
23. Vauclair S, Majo F, Durham AD, Ghyselinck NB, Barrandon
Y, Radtke F. Corneal epithelial cell fate is maintained during
repair by Notch1 signaling via the regulation of vitamin A
metabolism. Dev Cell 2007; 13:242-53. [PMID: 17681135]
24. Adachi W, Ulanovsky H, Li Y, Norman B, Davis J, Piatigorsky
J. Serial analysis of gene expression (SAGE) in the rat limbal
and central corneal epithelium. Invest Ophthalmol Vis Sci
2006; 47:3801-10. [PMID: 16936091]
25. Umemoto T, Yamato M, Nishida K, Kohno C, Yang J, Tano Y,
Okano T. Rat limbal epithelial side population cells exhibit a
distinct expression of stem cell markers that are lacking in
side population cells from the central cornea. FEBS Lett 2005;
579:6569-74. [PMID: 16297384]
26. Thomas PB, Liu YH, Zhuang FF, Selvam S, Song SW, Smith
RE,  Trousdale  MD,  Yiu  SC.  Identification  of  Notch-1
expression in the limbal basal epithelium. Mol Vis 2007;
13:337-44. [PMID: 17392684]
27. Ma A, Boulton M, Zhao B, Connon C, Cai J, Albon J. A role
for  Notch  signaling  in  human  corneal  epithelial
differentiation and proliferation. Invest Ophthalmol Vis Sci
2007; 48:3576-85. [PMID: 17652726]
28. Sun L, Sun TT, Lavker RM. Identification of a cytosolic NADP
+dependent  isocitrate  dehydrogenase  that  is  preferentially
expressed in bovine corneal epithelium. A corneal epithelial
crystallin.  J  Biol  Chem  1999;  274:17334-41.  [PMID:
10358094]
29. Sun L, Sun TT, Lavker RM. CLED: a calcium-linked protein
associated with early epithelial differentiation. Exp Cell Res
2000; 259:96-106. [PMID: 10942582]
30. Sun L, Ryan DG, Zhou M, Sun TT, Lavker RM. EEDA: a
protein associated with an early stage of stratified epithelial
differentiation.  J  Cell  Physiol  2006;  206:103-11.  [PMID:
15920738]
31. Saika S, Okada Y, Miyamoto T, Yamanaka O, Ohnishi Y,
Ooshima A, Liu CY, Weng D, Kao WW. Role of p38 MAP
kinase in regulation of cell migration and proliferation in
healing corneal epithelium. Invest Ophthalmol Vis Sci 2004;
45:100-9. [PMID: 14691160]
32. Guentchev M, McKay RD. Notch controls proliferation and
differentiation of stem cells in a dose-dependent manner. Eur
J Neurosci 2006; 23:2289-96. [PMID: 16706837]
33. Zhou W, Park I, Pins M, Kozlowski JM, Jovanovic B, Zhang J,
Lee C, Ilio K. Dual regulation of proliferation and growth
arrest in prostatic stromal cells by transforming growth factor-
beta1. Endocrinology 2003; 144:4280-4. [PMID: 12959966]
Molecular Vision 2008; 14:1041-1049 <http://www.molvis.org/molvis/v14/a125> © 2008 Molecular Vision
The print version of this article was created on 2 June 2008. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
1049